Reena Khanna, MD, MSc., FRCP(C)

Associate Professor of Medicine
Department of Medicine, Division of Gastroenterology
University of Western Ontario
London, Ontario

 

 
John Marshall, MD, MSc., FRCP(C), CAGF, AGAF 

Professor of Medicine
Director of the Division of Gastroenterology
McMaster University
Hamilton, Ontario

Sunday, November 20, 2022

7:30 am - 8:30 am

New and Emerging Therapies: Where is their place in clinical practice in 2022 and beyond?

Learning Objectives: 

  1. Review and discuss the current treatment landscape
  2. Discuss the potential impact of new and emerging therapeutic options
  3. Interpreting the benefit/risk of these new therapies and how do we best communicate these options to patients.

Dr. Reena Khanna is an Associate Professor of Medicine at the University of Western Ontario, and a Clinician Researcher in the Program for Experimental Medicine. She completed her MD and Internal Medicine residency at the University of Western Ontario, Gastroenterology fellowship at McMaster University.   Dr. Khanna completed an advanced fellowship in inflammatory bowel disease (IBD) at the Cleveland Clinic, followed by a research fellowship in international IBD clinical trials at the University of Western Ontario.   She completed an MSc. in clinical epidemiology at McMaster University.  Her clinical and research interest are clinical trial design, new therapeutics, outcome measures.  She has designed, conducted and published several studies, including the first cluster study in IBD.  Dr. Khanna holds international grants and most recently was awarded the Crohn’s Colitis Canada’s rising star award for her research contributions.

Dr. John Marshall completed his B.A. and M.D. at Queen’s University, and then undertook his residency training and M.Sc. in Clinical Epidemiology & Biostatistics at McMaster University. He is a Full Member of the Farncombe Family Digestive Health Research Institute. His publications include over 200 academic papers and book chapters and over 250 abstracts. Dr. Marshall is the Editor-in-Chief of the Journal of the Canadian Association of Gastroenterology (JCAG). He is also an Associate Editor of ACP Journal Club and Evidence-Based Medicine and an Editorial Board Member for the Journal of Crohn’s and Colitis. Past honours include the Canadian Association of Gastroenterology (CAG) Young Investigator Award (2008), the CAG Young Educator Award (2006), the CAG Visiting Clinical Professorship (2020), and Fellowship in both the American Gastroenterological Association (AGAF) and CAG (CAGF). Dr. Marshall’s clinical and research interests include inflammatory bowel disease, post-infectious irritable bowel syndrome, gastrointestinal bleeding, endoscopy, clinical trials, clinical epidemiology, health outcomes and health economics

Sponsored by: